TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $2,358,000 | -52.6% | 1,975,000 | -50.0% | 0.01% | 0.0% |
| Q2 2016 | $4,970,000 | +158.9% | 3,950,000 | +167.8% | 0.01% | +25.0% |
| Q1 2016 | $1,920,000 | -27.5% | 1,475,000 | -11.9% | 0.00% | -20.0% |
| Q4 2015 | $2,649,000 | +17.3% | 1,675,000 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $2,259,000 | +0.5% | 1,675,000 | +4.4% | 0.01% | +25.0% |
| Q2 2015 | $2,248,000 | -13.9% | 1,605,000 | -8.5% | 0.00% | -20.0% |
| Q1 2015 | $2,612,000 | +8.8% | 1,755,000 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $2,400,000 | -24.1% | 1,755,000 | -28.5% | 0.01% | -28.6% |
| Q3 2014 | $3,162,000 | -11.2% | 2,455,000 | -10.9% | 0.01% | -12.5% |
| Q2 2014 | $3,562,000 | – | 2,755,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Radcliffe Capital Management, L.P. | 70,783,000 | $69,363,000 | 6.27% |
| INCOME RESEARCH & MANAGEMENT | 14,978,000 | $14,536,000 | 5.17% |
| PIPER SANDLER & CO. | 5,000,000 | $4,852,000 | 3.63% |
| Western Asset Management Company, LLC | 42,946,000 | $42,102,000 | 3.46% |
| PenderFund Capital Management Ltd. | 4,000,000 | $5,225,000 | 1.45% |
| Bracebridge Capital, LLC | 5,500,000 | $5,335,000 | 0.85% |
| WESTWOOD HOLDINGS GROUP INC | 43,185,000 | $42,490,000 | 0.54% |
| CORBYN INVESTMENT MANAGEMENT INC/MD | 1,025,000 | $995,000 | 0.52% |
| LMR Partners LLP | 22,235,000 | $21,742,000 | 0.45% |
| JUPITER ASSET MANAGEMENT LTD | 35,000,000 | $34,357,000 | 0.36% |